BACKGROUND: Neuropsychologic testing is often used to infer neuropathologic processes, but clinicopathologic correlations for individual cognitive measures are based on a small number of published studies. OBJECTIVE: To examine the usefulness of the age- and education-adjusted Mayo Cognitive Factor Scales (MCFS) obtained at participants' initial assessments for predicting the presence or absence of pathologic Alzheimer disease (AD). DESIGN: This was a longitudinal study of a cohort of elderly patients with and without cognitive complaints who were followed up until death. Mayo Cognitive Factor Scales age- and education-adjusted standard scores from the participants' initial evaluations were used to calculate classification accuracy statistics for neuropathologic AD diagnosis obtained approximately 6 years after testing. Subjects with non-AD diagnoses or substantial non-AD-related changes were excluded from the study. SETTING: Academic medical center. PARTICIPANTS: One hundred two participants were evaluated clinically and underwent neuropathologic examination at autopsy. All were part of the Mayo Clinic Alzheimer's Disease Patient Registry or Alzheimer Disease Research Center. RESULTS: All Mayo Cognitive Factor Scale scores were significantly correlated with AD criteria. Logistic regression modeling including Mayo Cognitive Factor Scales Verbal Comprehension and Retention indices revealed high positive predictive value with moderate sensitivity and specificity for pathologic AD. CONCLUSION: Neuropsychologic test scores at initial evaluations were predictive of pathologic AD.
BACKGROUND: Neuropsychologic testing is often used to infer neuropathologic processes, but clinicopathologic correlations for individual cognitive measures are based on a small number of published studies. OBJECTIVE: To examine the usefulness of the age- and education-adjusted Mayo Cognitive Factor Scales (MCFS) obtained at participants' initial assessments for predicting the presence or absence of pathologic Alzheimer disease (AD). DESIGN: This was a longitudinal study of a cohort of elderly patients with and without cognitive complaints who were followed up until death. Mayo Cognitive Factor Scales age- and education-adjusted standard scores from the participants' initial evaluations were used to calculate classification accuracy statistics for neuropathologic AD diagnosis obtained approximately 6 years after testing. Subjects with non-AD diagnoses or substantial non-AD-related changes were excluded from the study. SETTING: Academic medical center. PARTICIPANTS: One hundred two participants were evaluated clinically and underwent neuropathologic examination at autopsy. All were part of the Mayo Clinic Alzheimer's DiseasePatient Registry or Alzheimer Disease Research Center. RESULTS: All Mayo Cognitive Factor Scale scores were significantly correlated with AD criteria. Logistic regression modeling including Mayo Cognitive Factor Scales Verbal Comprehension and Retention indices revealed high positive predictive value with moderate sensitivity and specificity for pathologic AD. CONCLUSION: Neuropsychologic test scores at initial evaluations were predictive of pathologic AD.
Authors: Christina E Wierenga; Nikki H Stricker; Ashley McCauley; Alan Simmons; Amy J Jak; Yu-Ling Chang; Lisa Delano-Wood; Katherine J Bangen; David P Salmon; Mark W Bondi Journal: Neuroimage Date: 2010-03-16 Impact factor: 6.556
Authors: Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon Journal: Neuropsychol Rev Date: 2008-03-18 Impact factor: 7.444
Authors: Susan De Santi; Elizabeth Pirraglia; William Barr; James Babb; Schantel Williams; Kimberley Rogers; Lidia Glodzik; Miroslaw Brys; Lisa Mosconi; Barry Reisberg; Steven Ferris; Mony J de Leon Journal: Neuropsychology Date: 2008-07 Impact factor: 3.295
Authors: Lisa Mosconi; Valentina Berti; Lidia Glodzik; Alberto Pupi; Susan De Santi; Mony J de Leon Journal: J Alzheimers Dis Date: 2010 Impact factor: 4.472
Authors: D G Clark; P Kapur; D S Geldmacher; J C Brockington; L Harrell; T P DeRamus; P D Blanton; K Lokken; A P Nicholas; D C Marson Journal: Cortex Date: 2014-01-16 Impact factor: 4.027
Authors: Lisa Delano-Wood; Mark W Bondi; Joshua Sacco; Norm Abeles; Amy J Jak; David J Libon; Andrea Bozoki Journal: J Int Neuropsychol Soc Date: 2009-11 Impact factor: 2.892
Authors: Rachel Mistur; Lisa Mosconi; Susan De Santi; Marla Guzman; Yi Li; Wai Tsui; Mony J de Leon Journal: J Clin Neurol Date: 2009-12-31 Impact factor: 3.077